MENU
AMRZ
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

AMRIZE AG (AMRZ) Earnings Date & Reports

Amrize is a building solutions company focused exclusively on the North American market... Show more

A.I. Advisor
published Earnings

AMRZ is expected to report earnings to fall 698.56% to 95 cents per share on August 06

AMRIZE AG AMRZ Stock Earnings Reports
Q2'26
Est.
$0.96
Q1'26
Missed
by $0.03
Q4'25
Missed
by $0.03
Q3'25
Missed
by $0.04
Q2'25
Missed
by $0.37
The last earnings report on April 29 showed earnings per share of -15 cents, missing the estimate of -12 cents. With 2.23M shares outstanding, the current market capitalization sits at 27.24B.
Jul 31, 2026

Amrize (AMRZ) Earnings Preview: Building Materials Titan Faces a Critical Mid-Year Test

Key Takeaways

  • Amrize is scheduled to report second-quarter 2026 results after the U.S. market close on Thursday, August 6, 2026, with a management webcast the following morning.
  • Consensus analyst estimates point to Q2 revenue of approximately $3.37 billion, representing year-over-year growth of roughly 4.6%, and earnings per share (EPS) around $0.96, up from $0.78 in the prior-year quarter.
  • The Building Materials segment is expected to remain the growth engine, driven by double-digit cement and aggregates volume momentum from infrastructure projects, data centers, and onshoring activity.
  • Building Envelope will be closely watched for signs of stabilization, following a difficult first quarter marked by soft roofing demand, price-cost headwinds, and a temporary plant disruption.
  • Investors are particularly focused on margin commentary, especially around input cost inflation—including sharply higher MDI (methylene diphenyl diisocyanate, a key chemical input for roofing) prices tied to petrochemical supply disruptions—and the effectiveness of April price increases.
  • The company's full-year 2026 guidance, reaffirmed in April, calls for revenue of $12.3 billion to $12.5 billion and adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) of $3.25 billion to $3.34 billion, and any update to that outlook will be a major market-moving event.

Earnings Context and Why It Matters

Amrize, the North American building materials leader spun off from Holcim in June 2025, approaches its second-quarter 2026 report at a pivotal moment. The stock has drifted toward the lower end of its 52-week range following a mixed first quarter that saw strong Building Materials results overshadowed by pronounced weakness in the Building Envelope roofing business. With approximately $27.5 billion in market capitalization and operations spanning over 1,000 sites across the U.S. and Canada, Amrize is a bellwether for North American construction activity. This report will offer investors the clearest read yet on whether the divergent performance between the company's two segments is narrowing—and whether pricing actions and seasonal demand can offset persistent cost inflation pressures.

Earnings Expectations

Analyst consensus for Amrize's second quarter of 2026 centers on revenue of roughly $3.37 billion, which would mark a year-over-year increase of approximately 4.6% from the $3.22 billion recorded in Q2 2025. On the bottom line, the consensus EPS estimate stands at approximately $0.96, up from $0.78 in the same quarter last year, reflecting expectations for improved profitability as the company moves past the seasonally weak first quarter.

The Building Materials segment is projected to extend its strong momentum. In Q1 2026, the segment delivered 12.9% revenue growth and a 230-basis-point expansion in adjusted EBITDA margin, fueled by cement volumes up 13.9% and aggregates volumes up 14.1%. April price increases across both cement and aggregates, along with fuel surcharges, are expected to provide additional tailwinds in the second quarter. The recently closed acquisition of PB Materials in West Texas should also contribute more meaningfully to results.

For the Building Envelope segment, the bar is lower following a difficult Q1 in which revenues fell 9.8% and segment adjusted EBITDA dropped 37.1%. Management implemented price increases in commercial and residential roofing in April, and investors will be scrutinizing whether those actions have begun to gain traction. The key wildcard is input costs: MDI prices have spiked sharply following supply disruptions linked to geopolitical events, creating a significant margin headwind that may take multiple quarters to fully pass through.

Historically, Amrize has delivered mixed results relative to consensus since its spin-off, with Q1 2026 adjusted EPS of -$0.16 missing estimates by $0.02, while the prior two quarters posted modest beats. The stock dropped more than 5% following the Q1 release, suggesting the market is sensitive to any disappointment.

AI Screener

For investors seeking to track earnings season opportunities or identify stocks with similar characteristics to Amrize, Tickeron's AI Screener offers a powerful solution. This AI-driven platform enables traders and investors to scan thousands of stocks and exchange-traded funds (ETFs) using customizable filters that span technical patterns, fundamental metrics, volatility profiles, and proprietary AI-generated signals. Users can narrow their search by industry, market capitalization, and performance criteria to surface trade ideas, breakout candidates, and emerging trends with greater speed and precision than manual screening. Whether you are monitoring building materials peers ahead of earnings or hunting for the next catalyst-driven opportunity, the AI Screener can help streamline your discovery process.

Market Reaction and Investor Sentiment

Sentiment around Amrize has cooled considerably since the start of 2026. The stock trades near $49.60, well below its 52-week high of $65.94 and the average analyst price target of approximately $63. In July, Truist Securities downgraded the stock to Hold from Buy and slashed its price target from $65 to $48, citing margin pressures in commercial roofing and limited near-term cement pricing upside. Wells Fargo and Citigroup have also trimmed their targets, though both maintain Buy-equivalent ratings.

On the other side of the ledger, insider buying has been notable—including purchases by the CEO and other senior executives—and the company's $1.0 billion share repurchase authorization signals management confidence. The analyst consensus remains a Moderate Buy with 12 Buy ratings and 8 Hold ratings, suggesting that while near-term caution has risen, the longer-term thesis around North American infrastructure and construction demand remains intact. The August 6 report represents a critical moment to either validate or further erode that confidence.

Forward Outlook and Key Factors to Monitor

Beyond the headline revenue and EPS figures, investors should pay close attention to several forward-looking indicators during Amrize's earnings call on August 7. The first is whether management reaffirms, adjusts, or narrows its full-year 2026 guidance. The current outlook—revenue of $12.3 billion to $12.5 billion and adjusted EBITDA of $3.25 billion to $3.34 billion—was set before the magnitude of MDI cost inflation and roofing demand softness became fully apparent. Any change here will immediately reset expectations for the back half of the year.

Cement and aggregates pricing trends will be another key area of focus. Management has guided for low-single-digit cement pricing growth and mid-single-digit aggregates pricing growth on a freight-adjusted basis for the full year. With April price increases now in effect for two full months of the quarter, the Q2 report should provide the first concrete evidence of whether those increases are sticking in the marketplace.

The trajectory of the Building Envelope segment deserves particular scrutiny. Management has pointed to an expected conversion of strong commercial new construction starts into roofing demand as projects advance through their construction cycle. Investors will want to see evidence that this conversion is beginning to materialize, along with signs that residential roofing demand is following normal seasonal patterns as the summer construction season progresses.

Finally, capital allocation remains an important theme. Amrize plans to invest approximately $900 million in capital expenditures (CapEx) in 2026, and any update on major capacity expansion projects—including the Saint Constant cement plant modernization in Canada—will shape expectations for future production capacity. Combined with the $1.0 billion buyback program and the newly initiated quarterly dividend of $0.11 per share, management's commentary on balancing growth investment with shareholder returns will round out the picture for long-term oriented investors.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
AMRZ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry ConstructionMaterials

Profile
Details